BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21847359)

  • 1. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.
    Cho HS; Kelly JD; Hayami S; Toyokawa G; Takawa M; Yoshimatsu M; Tsunoda T; Field HI; Neal DE; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Aug; 13(8):676-84. PubMed ID: 21847359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein.
    Hwang S; Kim S; Kim K; Yeom J; Park S; Kim I
    BMB Rep; 2020 Nov; 53(11):576-581. PubMed ID: 32684241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
    Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
    Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
    Chen G; Yu X; Zhang M; Zheng A; Wang Z; Zuo Y; Liang Q; Jiang D; Chen Y; Zhao L; Jiang L; Li D; Liao S
    Cytogenet Genome Res; 2019; 158(4):205-212. PubMed ID: 31434093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHMT2 Inhibition Induces Cell Death in Human Non-Small Cell Lung Cancer by Altering the Cholesterol Biosynthesis Pathway.
    Kim H; Choi SY; Lim J; Lindroth AM; Park YJ
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB.
    Park SE; Yi HJ; Suh N; Park YY; Koh JY; Jeong SY; Cho DH; Kim CS; Hwang JJ
    Oncotarget; 2016 Jun; 7(26):39796-39808. PubMed ID: 27174920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
    Pal A; Leung JY; Ang GCK; Rao VK; Pignata L; Lim HJ; Hebrard M; Chang KT; Lee VK; Guccione E; Taneja R
    Elife; 2020 Nov; 9():. PubMed ID: 33252038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EHMT2/G9a Inhibits Aortic Smooth Muscle Cell Death by Suppressing Autophagy Activation.
    Chen TQ; Hu N; Huo B; Masau JF; Yi X; Zhong XX; Chen YJ; Guo X; Zhu XH; Wei X; Jiang DS
    Int J Biol Sci; 2020; 16(7):1252-1263. PubMed ID: 32174799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.
    Kim SK; Kim K; Ryu JW; Ryu TY; Lim JH; Oh JH; Min JK; Jung CR; Hamamoto R; Son MY; Kim DS; Cho HS
    Int J Oncol; 2019 Jan; 54(1):65-76. PubMed ID: 30365075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVMBIX-01294, an inhibitor of the histone methyltransferase EHMT2, disrupts histone H3 lysine 9 (H3K9) dimethylation in the cleavage-stage porcine embryo.
    Park KE; Johnson CM; Cabot RA
    Reprod Fertil Dev; 2012; 24(6):813-21. PubMed ID: 22781932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
    Fan HT; Shi YY; Lin Y; Yang XP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.
    Singh N; Ramĩrez-Carvajal L; de Los Santos T; Golding MC; Long CR
    J Interferon Cytokine Res; 2016 Jan; 36(1):37-47. PubMed ID: 26418342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-seq based transcriptome analysis of EHMT2 functions in breast cancer.
    Kim K; Ryu TY; Ryu JW; Han TS; Jung CR; Son MY; Kim DS; Cho HS
    Biochem Biophys Res Commun; 2020 Apr; 524(3):672-676. PubMed ID: 32033749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
    Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
    Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHMT2 is a metastasis regulator in breast cancer.
    Kim K; Son MY; Jung CR; Kim DS; Cho HS
    Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression.
    Wang J; Xu H; Ge S; Xue C; Li H; Jing X; Liang K; Zhang X; Zhang C
    Cancer Biol Med; 2021 Oct; 19(6):836-49. PubMed ID: 34633777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer.
    Ryu TY; Kim K; Han TS; Lee MO; Lee J; Choi J; Jung KB; Jeong EJ; An DM; Jung CR; Lim JH; Jung J; Park K; Lee MS; Kim MY; Oh SJ; Hur K; Hamamoto R; Park DS; Kim DS; Son MY; Cho HS
    ISME J; 2022 May; 16(5):1205-1221. PubMed ID: 34972816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.